Possible immunotherapeutic potentiation with D-Fraction in prostate cancer cells

BACKGROUND: Prostate cancer remains the most common malignancy among elderly men and the second leading cause of cancer death in the United States. Although several conventional therapies are currently available, they have a low efficacy and the more effective treatment modalities need to be establi...

Descripción completa

Detalles Bibliográficos
Autores principales: Pyo, Paul, Louie, Brandon, Rajamahanty, Srinivas, Choudhury, Muhammad, Konno, Sensuke
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2613393/
https://www.ncbi.nlm.nih.gov/pubmed/19055833
http://dx.doi.org/10.1186/1756-8722-1-25

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2613393/
https://www.ncbi.nlm.nih.gov/pubmed/19055833
http://dx.doi.org/10.1186/1756-8722-1-25

Ejemplares similares